Neurol. praxi. 2019;20(6):451-454
Diagnostics and treatment of secondary progressive multiple sclerosis has been problematic. Current options of immunomodulatory
treatment of secondary progressive sclerosis multiplex are limited. Results or clinical studies show promising knowledges,
bringing possibilities for more effective treatment even for patients in secondary progressive multiple sclerosis. The work offers
current opinions and knowledges of the topic.
Published: December 1, 2019 Show citation